1472 results
Clinical outcomes after TAVI: Session 2
29 Nov 2022 – From PCR London Valves 2022
Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!
TAVI in TAVI
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
TAVI challenges: session 4
29 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.
TAVI complications: Session 4
29 Nov 2022 – From PCR London Valves 2022
With this selection of challenging cases, discover how to face various TAVI complications, such as: annular perforation, lost wire, aortoiliac rupture, bilateral coronary ostial occlusion, and much more!
Rapid-fire clinical cases: Session 5
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of cases submitted at PCR LV 2022 in this session: subacute thrombosis of a balloon-expandable aortic bioprosthesis, left axillary access for TAVI in a patient with two IMA grafts and a left side implanted pacemaker, avoiding paravalvular leak using computer simulation in bicuspid TAVI,...
Rapid-fire abstracts: Session 11
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!
Rapid-fire clinical cases: Session 7
29 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
TAVI-in-TAVI - A road map for successful lifetime management
29 Nov 2022 – From PCR London Valves 2022
Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
Clinical update and best practices for optimal large bore management with the MANTA closure device
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.
Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management
28 Nov 2022 – From PCR London Valves 2022
Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.
Rapid-fire abstracts: Session 5
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of right ventricular dysfunction on the outcomes of TAVI - Insights from nationwide database, impact of COVID-19 pandemic on TAVI activity: a worldwide registry, redo isolated tricuspid valve surgery - Prediction of...
Rapid-Fire clinical cases: Session 3
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!
Rapid-fire abstracts: Session 6
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...
TAVI challenges: session 2
28 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to learn how to treat TAVI with severe peripheral calcifications, a complex TAVI with extreme tortuous and horizontal aorta, or even TAVI in aortic regurgitation patient after failed attempt with commercial device.
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
TAVI challenges: session 3
28 Nov 2022 – From PCR London Valves 2022
View a radial access balloon aortic valvuloplasty adapting to the challenge of small arteries, a semi-inflated buddy balloon for percutaneous TAVR in severe calcified bicuspid aortic valve, and long-term outcome of TAVR in mucopolysaccharidosis type I-HS in this PCR LV 2022 session, among others!
Rapid-fire clinical cases: Session 4
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...
